Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 189
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Crit Care ; 24(1): 43, 2020 02 06.
Article in English | MEDLINE | ID: mdl-32028998

ABSTRACT

BACKGROUND: In patients with vasodilatory shock, plasma concentrations of angiotensin I (ANG I) and II (ANG II) and their ratio may reflect differences in the response to severe vasodilation, provide novel insights into its biology, and predict clinical outcomes. The objective of these protocol prespecified and subsequent post hoc analyses was to assess the epidemiology and outcome associations of plasma ANG I and ANG II levels and their ratio in patients with catecholamine-resistant vasodilatory shock (CRVS) enrolled in the Angiotensin II for the Treatment of High-Output Shock (ATHOS-3) study. METHODS: We measured ANG I and ANG II levels at baseline, calculated their ratio, and compared these results to values from healthy volunteers (controls). We dichotomized patients according to the median ANG I/II ratio (1.63) and compared demographics, clinical characteristics, and clinical outcomes. We constructed a Cox proportional hazards model to test the independent association of ANG I, ANG II, and their ratio with clinical outcomes. RESULTS: Median baseline ANG I level (253 pg/mL [interquartile range (IQR) 72.30-676.00 pg/mL] vs 42 pg/mL [IQR 30.46-87.34 pg/mL] in controls; P <  0.0001) and median ANG I/II ratio (1.63 [IQR 0.98-5.25] vs 0.4 [IQR 0.28-0.64] in controls; P <  0.0001) were elevated, whereas median ANG II levels were similar (84 pg/mL [IQR 23.85-299.50 pg/mL] vs 97 pg/mL [IQR 35.27-181.01 pg/mL] in controls; P = 0.9895). At baseline, patients with a ratio above the median (≥1.63) had higher ANG I levels (P <  0.0001), lower ANG II levels (P <  0.0001), higher albumin concentrations (P = 0.007), and greater incidence of recent (within 1 week) exposure to angiotensin-converting enzyme inhibitors (P <  0.00001), and they received a higher norepinephrine-equivalent dose (P = 0.003). In the placebo group, a baseline ANG I/II ratio <1.63 was associated with improved survival (hazard ratio 0.56; 95% confidence interval 0.36-0.88; P = 0.01) on unadjusted analyses. CONCLUSIONS: Patients with CRVS have elevated ANG I levels and ANG I/II ratios compared with healthy controls. In such patients, a high ANG I/II ratio is associated with greater norepinephrine requirements and is an independent predictor of mortality, thus providing a biological rationale for interventions aimed at its correction. TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02338843. Registered 14 January 2015.


Subject(s)
Angiotensin II/analysis , Angiotensin I/analysis , Shock/blood , Angiotensin I/blood , Angiotensin II/blood , Catecholamines/therapeutic use , Female , Humans , Male , Shock/physiopathology
2.
Anal Chem ; 89(17): 8981-8987, 2017 09 05.
Article in English | MEDLINE | ID: mdl-28612611

ABSTRACT

We describe the DRILL (dry ion localization and locomotion) device, which is an interface for electrospray ionization (ESI)-mass spectrometry (MS) that exploits a swirling flow to enable the use of inertial separation to prescribe different fates for electrosprayed droplets based on their size. This source adds a new approach to charged droplet trajectory manipulation which, when combined with hydrodynamic drag forces and electric field forces, provides a rich range of possible DRILL operational modes. Here, we experimentally demonstrate sensitivity improvement obtained via vortex-induced inertial sorting of electrosprayed droplets/ions: one possible mode of DRILL operation. In this mode, DRILL removes larger droplets while accelerating the remainder of the ESI plume, producing a high velocity stream of gas-enriched spray with small, highly charged droplets and ions and directing it toward the MS inlet. The improved signal-to-noise ratio (10-fold enhancement) in the detection of angiotensin I is demonstrated using the DRILL interface coupled to ESI-MS along with an improved limit of detection (10-fold enhancement, 100 picomole) in the detection of angiotensin II. The utility of DRILL has also been demonstrated by liquid chromatography (LC)-MS: a stable isotope labeled peptide cocktail was spiked into a complex native tissue extract and quantified by unscheduled multiple reaction monitoring on a TSQ Vantage. DRILL demonstrated improved signal strength (up to a 700-fold) for 8 out of 9 peptides and had no effects on the peak shape of the transitions.


Subject(s)
Peptides/analysis , Spectrometry, Mass, Electrospray Ionization/methods , Angiotensin I/analysis , Angiotensin I/metabolism , Angiotensin II/analysis , Angiotensin II/metabolism , Chromatography, High Pressure Liquid , Humans , Isotope Labeling , Limit of Detection , Peptides/chemistry , Spectrometry, Mass, Electrospray Ionization/instrumentation
3.
J Fluoresc ; 26(1): 81-6, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26452351

ABSTRACT

Angiotensin-(1-7) is an important active component in the renin-angiotensin-system. Due to its cardio protective effects it is now under investigation in combination with antioxidants as a reperfusion solution. The combination showed impressive effects on isolated hearts of male Wistar rats after induced ischemia. In this work a high performance liquid chromatography method with fluorescence detection was developed for the first time for in-process measurements as well as for stability tests of the peptide in the novel antioxidant-containing Karal® solution. For fluorescence detection of angiotensin-(1-7) fluorescamine as derivatization dye was applied. Under optimized conditions the method showed linearity over the range of 50 to 5000 ng/mL with R(2) of 0.9988 and an overall precision better than 5.0 %. LOD and LOQ were determined to be in the femtomol range on column. It was found that stability of angiotensin-(1-7) could be significantly improved in the antioxidant containing preparation compared to aqueous solutions.


Subject(s)
Angiotensin I/analysis , Fluorescence , Peptide Fragments/analysis , Animals , Chromatography, High Pressure Liquid , Male , Microscopy, Fluorescence , Molecular Conformation , Rats , Rats, Wistar
4.
Anal Chem ; 87(7): 3902-10, 2015 Apr 07.
Article in English | MEDLINE | ID: mdl-25759941

ABSTRACT

There is great interest in the development of integrated tools allowing for miniaturized sample processing, including solid phase extraction (SPE). We introduce a new format for microfluidic SPE relying on C18-functionalized magnetic beads that can be manipulated in droplets in a digital microfluidic platform. This format provides the opportunity to tune the amount (and potentially the type) of stationary phase on-the-fly, and allows the removal of beads after the extraction (to enable other operations in same device-space), maintaining device reconfigurability. Using the new method, we employed a design of experiments (DOE) operation to enable automated on-chip optimization of elution solvent composition for reversed phase SPE of a model system. Further, conditions were selected to enable on-chip fractionation of multiple analytes. Finally, the method was demonstrated to be useful for online cleanup of extracts from dried blood spot (DBS) samples. We anticipate this combination of features will prove useful for separating a wide range of analytes, from small molecules to peptides, from complex matrices.


Subject(s)
Aminoquinolines/analysis , Angiotensin I/analysis , Dried Blood Spot Testing , Magnetite Nanoparticles/chemistry , Microfluidic Analytical Techniques , Solvents/chemistry , Equipment Design , Humans , Microfluidic Analytical Techniques/instrumentation , Microfluidic Analytical Techniques/methods , Solid Phase Extraction
5.
Anal Chem ; 87(5): 2702-9, 2015 Mar 03.
Article in English | MEDLINE | ID: mdl-25664891

ABSTRACT

While the use of sodium dodecyl sulfate (SDS) in separation buffers allows efficient analysis of complex mixtures, its presence in the sample matrix is known to severely interfere with the mass-spectrometric characterization of analyte molecules. In this article, we report a microfluidic device that addresses this analytical challenge by enabling inline electrospray ionization mass spectrometry (ESI-MS) of low molecular weight cationic samples prepared in SDS containing matrices. The functionality of this device relies on the continuous extraction of analyte molecules into an SDS-free solvent stream based on the free-flow zone electrophoresis (FFZE) technique prior to their ESI-MS analysis. The reported extraction was accomplished in our current work in a glass channel with microelectrodes fabricated along its sidewalls to realize the desired electric field. Our experiments show that a key challenge to successfully operating such a device is to suppress the electroosmotically driven fluid circulations generated in its extraction channel that otherwise tend to vigorously mix the liquid streams flowing through this duct. A new coating medium, N-(2-triethoxysilylpropyl) formamide, recently demonstrated by our laboratory to nearly eliminate electroosmotic flow in glass microchannels was employed to address this issue. Applying this surface modifier, we were able to efficiently extract two different peptides, human angiotensin I and MRFA, individually from an SDS containing matrix using the FFZE method and detect them at concentrations down to 3.7 and 6.3 µg/mL, respectively, in samples containing as much as 10 mM SDS. Notice that in addition to greatly reducing the amount of SDS entering the MS instrument, the reported approach allows rapid solvent exchange for facilitating efficient analyte ionization desired in ESI-MS analysis.


Subject(s)
Angiotensin I/analysis , Cations/isolation & purification , Electrophoresis/methods , Microfluidic Analytical Techniques/methods , Nuclear Proteins/analysis , Sodium Dodecyl Sulfate/chemistry , Spectrometry, Mass, Electrospray Ionization/methods , Angiotensin I/chemistry , DNA-Binding Proteins , Humans , Molecular Weight , Nuclear Proteins/chemistry , Solvents/chemistry
6.
Rapid Commun Mass Spectrom ; 29(18): 1651-60, 2015 Sep 30.
Article in English | MEDLINE | ID: mdl-26467117

ABSTRACT

RATIONALE: The prohormone angiotensin I (ANG I) [amino acid sequence: DRVYIHPFHL] and other structurally related peptide hormones play an essential role in the regulation of the water and electrolyte balance in the human body as well as blood pressure. ANG I is a biomarker for hypertension and diabetes. Therefore, well-characterized pure reference materials and comparable and SI-traceable analytical characterization methods are required to establish reference measurement systems (RMS) for laboratory medicine. METHODS: Two analytical characterization methods based on liquid chromatography/mass spectrometry (LC/MS) systems with electrospray ionization have been developed and validated in-house. Both high-resolution MS (hrMS) and hybrid-tandem MS/MS were used for the identification and quantification of the major structurally related peptide impurities of ANG I. The impurities were quantified by use of external calibrations with original impurity standards. Mass fraction impurity values and corresponding expanded measurement uncertainties were calculated. RESULTS: Five structurally related degradation products were detected as major impurities in a 'pure' ANG I material. The peptides ANG (2-10) [RVYIHPFHL], ANG II [DRVYIHPF] and three ANG I isomers [DRVYLHPFHL, DRVYIHPFHI and DRVYLHPFHI] were identified and corresponding mass fraction values calculated that range from 0.66 to 4.86 mg/g. CONCLUSIONS: The mass fraction values for the major related peptide impurities in the ANG I material obtained with both LC/hrMS and LC/MS/MS systems are in excellent agreement. This study emphasizes the importance of mass spectrometric techniques for application to mass balance approaches for mass fraction value and uncertainty assignment of impurities in 'pure' substance reference materials for peptides.


Subject(s)
Angiotensin I/analysis , Angiotensin I/chemistry , Chromatography, Liquid/standards , Tandem Mass Spectrometry/standards , Angiotensin I/standards , Biomarkers/analysis , Calibration , Chromatography, Liquid/methods , Humans , Linear Models , Recombinant Proteins/analysis , Recombinant Proteins/chemistry , Recombinant Proteins/standards , Reference Standards , Reproducibility of Results , Sensitivity and Specificity , Tandem Mass Spectrometry/methods
7.
Anal Chem ; 85(21): 10174-9, 2013 Nov 05.
Article in English | MEDLINE | ID: mdl-24125033

ABSTRACT

A novel overtone mobility spectrometry (OMS) instrument utilizing a gridless elimination mechanism and cooperative radio frequency confinement is described. The gridless elimination region uses a set of mobility-discriminating radial electric fields that are designed so that the frequency of field application results in selective transmission and elimination of ions. To neutralize ions with mobilities that do not match the field application frequency, active elimination regions radially defocus ions toward the lens walls. Concomitantly, a lens-dependent radio frequency waveform is applied to the transmission regions of the drift tube resulting in radial confinement for mobility-matched ions. Compared with prior techniques, which use many grids for ion elimination, the new gridless configuration substantially reduces indiscriminate ion losses. A description of the apparatus and elimination process, including detailed simulations showing how ions are transmitted and eliminated is presented. A prototype 28 cm long OMS instrument is shown to have a resolving power of 20 and is capable of attomole detection limits of a model peptide (angiotensin I) spiked into a complex mixture (in this case peptides generated from digestion of ß-casein with trypsin).


Subject(s)
Mass Spectrometry/methods , Angiotensin I/analysis , Angiotensin I/chemistry , Caseins/chemistry , Trypsin/chemistry
8.
Anal Chem ; 85(9): 4384-91, 2013 May 07.
Article in English | MEDLINE | ID: mdl-23537004

ABSTRACT

Electrospun polymeric nanofibers (polyacrylonitrile, poly(vinyl alcohol), and SU-8 photoresist) and carbon nanofibers pyrolyzed to final temperatures of 600, 800, and 900 °C were used as substrates for surface-assisted laser desorption/ionization (SALDI) and matrix-enhanced surface-assisted laser desorption/ionization (ME-SALDI) analyses. Sample preparation of polymeric analytes using the electrospun target plate for SALDI analysis is simple and fast. Signal enhancements for poly(ethylene glycol) were noted with nanofibrous carbon substrates compared to those obtained with commercially available stainless steel plates when no organic matrix is used. Minimal fragmentation was observed. Poly(ethylene glycol) with a molecular weight as high as 900 000 Da was successfully detected using the carbon nanofibrous substrate processed to 800 °C, which is the highest molecular weight that has been studied by SALDI. Small molecules were detected using nanofibrous carbon substrate processed to 800 °C. For example, spectra of glucose, arginine, and crystal violet were obtained with no observed interferences in the low molecular weight range. The SALDI results show enhanced shot-to-shot reproducibility compared to matrix-assisted laser desorption/ionization (MALDI). High-quality polystyrene spectra were obtained for the first time using SALDI nanofibrous polyacrylonitrile substrates. Significantly enhanced signal-to-noise ratios were obtained using ME-SALDI compared to conventional MALDI or SALDI for the studied analytes. A detection limit of 400 amol was achieved for angiotensin I using the nanofibrous carbon ME-SALDI substrate.


Subject(s)
Electrochemical Techniques , Lasers , Nanofibers/chemistry , Nanotubes, Carbon/chemistry , Angiotensin I/analysis , Arginine/analysis , Gentian Violet/analysis , Glucose/analysis , Polymers/analysis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Surface Properties , Temperature
9.
Reprod Biol Endocrinol ; 11: 5, 2013 Jan 22.
Article in English | MEDLINE | ID: mdl-23339712

ABSTRACT

BACKGROUND: In humans, trophoblast invasion, vascular remodeling and placental development are critical to determine the fate of pregnancy. Since guinea-pigs (GP) and humans share common pregnancy features including extensive trophoblast invasion, transformation of the uterine spiral arteries and a haemomonochorial placenta, the GP animal model was deemed suitable to extend our knowledge on the spatio-temporal immunoreactive expression of the vasodilator arpeptide of the renin-angiotensin system, angiotensin-(1-7) [Ang-(1-7)] and its main generating enzyme, angiotensin converting enzyme 2 (ACE2). METHODS: Utero-placental units were collected in days 15, 20, 40 and 60 of a 64-67 day long pregnancy in 25 Pirbright GP. Ang-(1-7) and ACE2 expression in utero-placental units were evaluated by immunohistochemistry. RESULTS: Ang-(1-7) and ACE2 were detected in the endothelium and syncytiotrophoblast of the labyrinthine placenta, interlobium, subplacenta, giant cells, syncytial sprouts, syncytial streamers, and myometrium throughout pregnancy. In late pregnancy, perivascular or intramural trophoblasts in spiral and mesometrial arteries expressed both factors. Immunoreactive Ang-(1-7) and ACE2 were present in decidua and in the vascular smooth muscle of spiral, myometrial and mesometrial arteries, which also express kallikrein (Kal), the bradykinin receptor 2 (B2R), vascular endothelial growth factor (VEGF) and its type 2 receptor (KDR), but no endothelial nitric oxide synthase (eNOS). In addition, the signal of Ang-(1-7) and ACE2 was especially remarkable in giant cells, which also show Kal, B2R. eNOS, VEGF and KDR. CONCLUSIONS: The spatio-temporal expression of Ang-(1-7) and ACE2 in GP, similar to that of humans, supports a relevant evolutionary conserved function of Ang-(1-7) and ACE2 in decidualization, trophoblast invasion, vascular remodeling and placental flow regulation, as well as the validity of the GP model to understand the local adaptations of pregnancy. It also integrates Ang-(1-7) to the utero-placental vasodilatory network. However, its antiangiogenic effect may counterbalance the proangiogenic activity of some of the other vasodilator components.


Subject(s)
Angiotensin I/analysis , Peptide Fragments/analysis , Peptidyl-Dipeptidase A/analysis , Placenta/chemistry , Uterus/chemistry , Angiotensin-Converting Enzyme 2 , Animals , Decidua/chemistry , Endothelial Cells/chemistry , Female , Gestational Age , Guinea Pigs , Immunohistochemistry , Models, Animal , Muscle, Smooth, Vascular/chemistry , Pregnancy , Trophoblasts/chemistry , Uterine Artery/chemistry , Uterus/blood supply
10.
Methods ; 56(2): 213-22, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22387391

ABSTRACT

An immuno-Matrix Assisted Laser Desorption/Ionization (iMALDI) method has been developed using anti-IgG beads to capture anti-AngI and anti-AngII antibodies, which are incubated with a ∼50µL plasma sample to which known amounts of stable-isotope-labeled AngI and AngII have been added. After a short incubation time, the beads are washed, placed directly on a MALDI target, and analyzed by mass spectrometry (MS) and tandem mass spectrometry (MS/MS). The iMALDI assay developed can detect and quantify angiotensin I (AngI) and angiotensin II (AngII) in human plasma. This assay has a Limit of Detection (LOD) of ∼10amol/µL (or ∼13pg/mL AngI and ∼11pg/mL AngII), at a S/N of 2:1, using only one-tenth of the antibody beads which were incubated with a 50-µL plasma sample. This LOD is within the relevant range of patient samples. Little or no angiotensin generation period is required, resulting in a rapid assay. Correlation coefficients for the standard curves are >0.99, with a linear range of 4-100fmol/µL (5-130ng/mL) and 100-2500amol/µL (106-2614pg/mL) for AngI and AngII, respectively. This duplexed assay can quantify AngI and AngII peptide levels simultaneously, in plasma from normotensive and hypertensive patients. The assay can detect changes in the levels of these peptides over time, which will allow quantitation of plasma renin and ACE activities.


Subject(s)
Angiotensin II/blood , Angiotensin I/blood , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Angiotensin I/analysis , Angiotensin I/chemistry , Angiotensin II/analysis , Angiotensin II/chemistry , Animals , Antibodies/chemistry , Calibration , Enzyme Activation , Enzyme Assays , Humans , Immunoglobulin G/chemistry , Isotope Labeling , Limit of Detection , Plasma/chemistry , Reference Values , Renin/analysis , Renin/blood , Renin/chemistry , Sensitivity and Specificity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/instrumentation , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/standards , Tandem Mass Spectrometry
11.
Anal Chem ; 84(17): 7422-30, 2012 Sep 04.
Article in English | MEDLINE | ID: mdl-22876737

ABSTRACT

An electrostatic-spray ionization (ESTASI) method has been used for mass spectrometry (MS) analysis of samples deposited in or on an insulating substrate. The ionization is induced by a capacitive coupling between an electrode and the sample. In practice, a metallic electrode is placed close to but not in direct contact with the sample. Upon application of a high voltage pulse to the electrode, an electrostatic charging of the sample occurs leading to a bipolar spray pulse. When the voltage is positive, the bipolar spray pulse consists first of cations and then of anions. This method has been applied to a wide range of geometries to emit ions from samples in a silica capillary, in a disposable pipet tip, in a polymer microchannel, or from samples deposited as droplets on a polymer plate. Fractions from capillary electrophoresis were collected on a polymer plate for ESTASI MS analysis.


Subject(s)
Spectrometry, Mass, Electrospray Ionization/methods , Angiotensin I/analysis , Anions/chemistry , Cations/chemistry , Electrodes , Polymers/chemistry , Spectrometry, Mass, Electrospray Ionization/instrumentation , Static Electricity
12.
Anal Chem ; 84(18): 7626-32, 2012 Sep 18.
Article in English | MEDLINE | ID: mdl-22877355

ABSTRACT

Matrix-assisted laser desorption/ionization (MALDI) has proven an effective tool for fast and accurate determination of many molecules. However, the detector sensitivity and chemical noise compromise the detection of many invaluable low-abundance molecules from biological and clinical samples. To challenge this limitation, we developed a targeted analyte detection (TAD) technique. In TAD, the target analyte is selectively elevated by spiking a known amount of that analyte into the sample, thereby raising its concentration above the noise level, where we take advantage of the improved sensitivity to detect the presence of the endogenous analyte in the sample. We assessed TAD on three peptides in simple and complex background solutions with various exogenous analyte concentrations in two MALDI matrices. TAD successfully improved the limit of detection (LOD) of target analytes when the target peptides were added to the sample in a concentration close to optimum concentration. The optimum exogenous concentration was estimated through a quantitative method to be approximately equal to the original LOD for each target. Also, we showed that TAD could achieve LOD improvements on an average of 3-fold in a simple and 2-fold in a complex sample. TAD provides a straightforward assay to improve the LOD of generic target analytes without the need for costly hardware modifications.


Subject(s)
Peptides/analysis , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Amyloid beta-Peptides/analysis , Angiotensin I/analysis , Angiotensin II/analysis , Limit of Detection , Peptide Fragments/analysis , Peptides/standards , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/standards
13.
Anal Chem ; 83(11): 4076-84, 2011 Jun 01.
Article in English | MEDLINE | ID: mdl-21520968

ABSTRACT

First examples of highly charged ions in mass spectrometry (MS) produced from the solid state without using solvent during either sample preparation or mass measurement are reported. Matrix material, matrix/analyte homogenization time and frequency, atmospheric pressure (AP) to vacuum inlet temperature, and mass analyzer ion trap conditions are factors that influence the abundance of the highly charged ions created by laserspray ionization (LSI). LSI, like matrix-assisted laser desorption/ionization (MALDI), uses laser ablation of a matrix/analyte mixture from a surface to produce ions. Preparing the matrix/analyte sample without the use of solvent provides the ability to perform total solvent-free analysis (TSA) consisting of solvent-free ionization and solvent-free gas-phase separation using ion mobility spectrometry (IMS) MS. Peptides and small proteins such as non-ß-amyloid components of Alzheimer's disease and bovine insulin are examples in which LSI and TSA were combined to produce multiply charged ions, similar to electrospray ionization, but without the use of solvent. Advantages using solvent-free LSI and IMS-MS include simplicity, rapid data acquisition, reduction of sample complexity, and the potential for an enhanced effective dynamic range. This is achieved by more inclusive ionization and improved separation of mixture components as a result of multiple charging.


Subject(s)
Ions/chemistry , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods , Angiotensin I/analysis , Animals , Atmospheric Pressure , Cattle , Insulin/analysis , Peptides/analysis , Solvents/chemistry
14.
Anal Biochem ; 412(1): 40-6, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21185255

ABSTRACT

Over the past decade, a number of endogenous peptides and endogenous peptide analogs have been employed in therapeutics and as diagnostic markers. The use of peptides as standards for the absolute quantification of proteins has become commonly accepted. Consequently, the requirement for standard peptides traceable to the International System of Units with low associated measurement uncertainty, and for accurate methods of peptide quantification, has increased. Here we describe a method of peptide quantification involving microwave-assisted acid hydrolysis followed by gas chromatography-mass spectrometry that enables traceable quantification of a peptide by exact matching isotope dilution mass spectrometry where the total hydrolysis time required is only 3h. A solution of angiotensin I was quantified using this method, and the results were in agreement with those obtained previously using an oven hydrolysis liquid chromatography-tandem mass spectrometry method.


Subject(s)
Gas Chromatography-Mass Spectrometry/methods , Microwaves , Peptides/analysis , Peptides/standards , Amino Acid Sequence , Amino Acids/chemistry , Amino Acids/standards , Angiotensin I/analysis , Gas Chromatography-Mass Spectrometry/standards , Hydrolysis , Molecular Sequence Data , Temperature , Time Factors
15.
Anal Biochem ; 408(1): 124-31, 2011 Jan 01.
Article in English | MEDLINE | ID: mdl-20807498

ABSTRACT

This work demonstrates that amino acid analysis based on isotope dilution mass spectrometry (IDMS) can be applied to quantify proteins having different complexities and natures. Five proteins and one decapeptide were selected for the study: C-reactive protein (CRP), beta-2-microglobulin (B2M), cystatine C (CysC), human serum albumin (HSA), Ara h1, and angiotensin I. The quantification was based on the determination of four amino acids, proline (Pro), isoleucine (Ile), valine (Val), and phenylalanine (Phe) within a working range between 5 and 100 pmol/injection of each amino acid, after 60 min digestion with HCl at 150°C. The amino acids were selected taking into account their abundance in the protein sequence and to include the more difficult to break peptide bonds. Quantification of the protein amounts calculated from each amino acid is consistent, indicating that the method is working reliably. This consistency points to a complete hydrolysis of the proteins. The trueness of the method was proven when dry mass determination after dialysis was applied to HSA and CRP and the results were compared to those from amino acid analysis. Traceability to SI was assured by extensive characterisation of the amino acid calibrants by nuclear magnetic resonance, neutron activation analysis, and Karl Fischer titration.


Subject(s)
Amino Acids/analysis , Mass Spectrometry/methods , Proteins/analysis , Amino Acids/isolation & purification , Amino Acids/standards , Angiotensin I/analysis , Antigens, Plant/analysis , C-Reactive Protein/analysis , Calibration , Chromatography, High Pressure Liquid/methods , Cystatins/analysis , Glycoproteins/analysis , Humans , Hydrolysis , Indicator Dilution Techniques , Isotope Labeling , Mass Spectrometry/standards , Membrane Proteins , Plant Proteins/analysis , Serum Albumin/analysis
16.
Anal Chem ; 81(12): 4778-87, 2009 Jun 15.
Article in English | MEDLINE | ID: mdl-19438247

ABSTRACT

Ion mobility spectrometry (IMS) has been increasingly employed in a number of applications. When coupled to mass spectrometry (MS), IMS becomes a powerful analytical tool for separating complex samples and investigating molecular structure. Therefore, improvements in IMS-MS instrumentation, e.g., IMS resolving power and sensitivity, are highly desirable. Implementation of an ion trap for accumulation and pulsed ion injection to IMS based on the ion funnel has provided considerably increased ion currents and thus a basis for improved sensitivity and measurement throughput. However, large ion populations may manifest Coulombic effects contributing to the spatial dispersion of ions traveling in the IMS drift tube and reduction in the IMS resolving power. In this study, we present an analysis of Coulombic effects on IMS resolution. Basic relationships have been obtained for the spatial evolution of ion packets due to Coulombic repulsion. The analytical relationships were compared with results of a computer model that simulates IMS operation based on a first principles approach. Initial experimental results reported here are consistent with the computer modeling. A noticeable decrease in the IMS resolving power was observed for ion populations of >10,000 elementary charges. The optimum IMS operation conditions which would minimize the Coulombic effects are discussed.


Subject(s)
Ions/analysis , Mass Spectrometry/methods , Angiotensin I/analysis , Ions/chemistry , Mass Spectrometry/instrumentation , Models, Theoretical
17.
Regul Pept ; 154(1-3): 23-31, 2009 Apr 10.
Article in English | MEDLINE | ID: mdl-19323983

ABSTRACT

To clarify the role of Angiotensin II (Ang II) in the sensory system and especially in the trigeminal ganglia, we studied the expression of angiotensinogen (Ang-N)-, renin-, angiotensin converting enzyme (ACE)- and cathepsin D-mRNA, and the presence of Ang II and substance P in the rat and human trigeminal ganglia. The rat trigeminal ganglia expressed substantial amounts of Ang-N- and ACE mRNA as determined by quantitative real time PCR. Renin mRNA was untraceable in rat samples. Cathepsin D was detected in the rat trigeminal ganglia indicating the possibility of existence of pathways alternative to renin for Ang I formation. In situ hybridization in rat trigeminal ganglia revealed expression of Ang-N mRNA in the cytoplasm of numerous neurons. By using immunocytochemistry, a number of neurons and their processes in both the rat and human trigeminal ganglia were stained for Ang II. Post in situ hybridization immunocytochemistry reveals that in the rat trigeminal ganglia some, but not all Ang-N mRNA-positive neurons marked for Ang II. In some neurons Substance P was found colocalized with Ang II. Angiotensins from rat trigeminal ganglia were quantitated by radioimmunoassay with and without prior separation by high performance liquid chromatography. Immunoreactive angiotensin II (ir-Ang II) was consistently present and the sum of true Ang II (1-8) octapeptide and its specifically measured metabolites were found to account for it. Radioimmunological and immunocytochemical evidence of ir-Ang II in neuronal tissue is compatible with Ang II as a neurotransmitter. In conclusion, these results suggest that Ang II could be produced locally in the neurons of rat trigeminal ganglia. The localization and colocalization of neuronal Ang II with Substance P in the trigeminal ganglia neurons may be the basis for a participation and function of Ang II in the regulation of nociception and migraine pathology.


Subject(s)
Angiotensinogen/analysis , Angiotensinogen/metabolism , Neurons/metabolism , Trigeminal Ganglion/metabolism , Adult , Angiotensin I/analysis , Angiotensin II/analysis , Angiotensinogen/genetics , Animals , Humans , Immunohistochemistry , In Situ Hybridization , Male , RNA, Messenger/metabolism , Radioimmunoassay , Rats , Rats, Inbred WKY
18.
Science ; 214(4523): 921-3, 1981 Nov 20.
Article in English | MEDLINE | ID: mdl-6272392

ABSTRACT

Cells of the homogeneous hybrid line neuroblastoma x glioma (NG108-15) have many neuronal properties. Immunocytochemical tests show that they contain both immunoreactive renin and angiotensin; direct radioimmunoassays show that they are positive for renin, angiotensin I, and angiotensin II; enzymatic assays show that they contain angiotensinogen and converting enzyme as well. The renin appears to be present in an enzymatically inactive form that can be activated by trypsin and then blocked by antiserum to purified mouse submaxillary renin. Renin concentration and activity are increased by enhancing cellular differentiation with dibutyryl cyclic adenosine monophosphate or by serum withdrawal. These findings demonstrate a complete renin-angiotensin system within these neuron-like cells, and suggest that activation of intracellular renin could generate angiotensin II.


Subject(s)
Angiotensin II/analysis , Angiotensin I/analysis , Angiotensins/analysis , Glioma/metabolism , Hybrid Cells/metabolism , Neuroblastoma/metabolism , Renin/metabolism , Animals , Cell Line , Cricetinae , Mice , Peptidyl-Dipeptidase A/metabolism , Radioimmunoassay , Rats
19.
Org Biomol Chem ; 7(22): 4598-603, 2009 Nov 21.
Article in English | MEDLINE | ID: mdl-19865694

ABSTRACT

A dynamic combinatorial library of metal-dye complexes was obtained by reacting aqueous solutions of the dyes Methyl Calcein Blue, Arsenazo I, and Xylenol Orange with CuCl(2) and NiCl(2). The mixture gave a characteristic UV-Vis response upon addition of the peptide hormones angiotensin I and angiotensin II. This allowed distinguishing pure samples of peptide hormones from mixtures. The discriminatory power of the sensor was enhanced when the several UV/Vis measurements were performed during the equilibration process of the library.


Subject(s)
Coloring Agents/chemistry , Combinatorial Chemistry Techniques/methods , Metals/chemistry , Peptide Hormones/analysis , Angiotensin I/analysis , Angiotensin II/analysis , Discriminant Analysis , Kinetics , Spectrophotometry, Ultraviolet , Time Factors , Titrimetry
20.
Talanta ; 205: 120093, 2019 Dec 01.
Article in English | MEDLINE | ID: mdl-31450431

ABSTRACT

To extend the ion structure analysis capability of Fourier transform mass spectrometry (FT-MS), both time-domain and frequency-domain methods have been developed to extract ion collision cross sections (CCS) from high resolution mass spectra in Fourier transform ion cyclotron resonance (FT-ICR) cells. In this study, a new frequency-domain method, namely the line shape fitting method, was proposed to calculate ion CCSs from FT-ICR mass spectra line shape. Besides experimental data, simulated data with precisely controlled signal to noise levels and decay factors were also applied to characterize this method. Compared with the linewidth correction method previously proposed by our group, this line shape fitting method is more tolerant to noise, data length, and sampling rate, thus providing more consistent results. More importantly, CCS measurements of angiotensin I, bradykinin, ubiquitin and cytochrome c show that the resolving power is improved with the new method.


Subject(s)
Mass Spectrometry/methods , Angiotensin I/analysis , Bradykinin/analysis , Cytochromes c/analysis , Fourier Analysis , Least-Squares Analysis , Ubiquitin/analysis
SELECTION OF CITATIONS
SEARCH DETAIL